COVID-19 Evidence Accelerator Therapeutics Lab Meeting 2/18/2021

Existing therapeutics, new applications in COVID-19. That’s the theme we’ll be discussing on Thursday, as we look at the desire to continue success of treating COVID-19 by repurposing drugs which are already on the market. As you might expect, there is a lot to discuss, and our agenda includes:

  1. End-to-End Evidence Framework
  2. Case Study: Anticoagulant Use in the VA
  3. Panel Discussion of Ongoing Work with:
    1. Dr. Martin Landray (RECOVERY),
    2. Dr. Chris Seymour (REMAP-CAP for COVID-19),
    3. Dr. Neil Aggarwal (ACTIV at NIH) and
    4. Dr. Susanna Naggie (DCRI)